IRIS
RUSSO, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 211
NA - Nord America 42
AS - Asia 38
SA - Sud America 2
Totale 293
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 101
IE - Irlanda 52
US - Stati Uniti d'America 41
PL - Polonia 22
FR - Francia 20
VN - Vietnam 18
CN - Cina 8
DE - Germania 6
GB - Regno Unito 4
JP - Giappone 4
SG - Singapore 3
CO - Colombia 2
IN - India 2
SE - Svezia 2
CA - Canada 1
ES - Italia 1
GR - Grecia 1
KR - Corea 1
NL - Olanda 1
PH - Filippine 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 293
Salva come PNG Salva come JPEG
Città #
Dublin 52
Messina 45
Warsaw 22
Dong Ket 18
Ashburn 6
Boardman 5
Columbus 4
London 4
Paris 3
Washington 3
Bogotá 2
Council Bluffs 2
Florence 2
Milan 2
Mountain View 2
Shanghai 2
Tarzo 2
Alassio 1
Bracke 1
Cassano D'adda 1
Catania 1
Como 1
Duncan 1
Houston 1
Istanbul 1
Milpitas 1
Mumbai 1
Nadiad 1
New York 1
Norwalk 1
Ottawa 1
Palo Alto 1
Redmond 1
Rome 1
Somerville 1
Sterling 1
Talavera 1
Tong 1
Tübingen 1
Valdemoro 1
Venice 1
Villeneuve-le-roi 1
Totale 201
Salva come PNG Salva come JPEG
Nome #
Exosomal PD-L1 expression and dynamic changes of immune response associated cytokines as predictive biomarkers for immune checkpoint blockage with PD-1/PD-L1 inhibitors in advanced/metastatic non-small cell lung cancer, file de3e52b2-7e2c-762d-e053-3705fe0a30e0 87
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives, file de3e52af-95d1-762d-e053-3705fe0a30e0 32
Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario, file de3e52b3-17ae-762d-e053-3705fe0a30e0 31
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going, file de3e52b1-5772-762d-e053-3705fe0a30e0 21
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review, file de3e52b1-5302-762d-e053-3705fe0a30e0 19
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel, file de3e52b3-6c91-762d-e053-3705fe0a30e0 18
Nab-paclitaxel and trastuzumab combination: A promising approach for neoadjuvant treatment in HER2-positive breast cancer, file de3e52b0-d488-762d-e053-3705fe0a30e0 15
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status, file de3e52b0-d883-762d-e053-3705fe0a30e0 15
Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site, file de3e52b3-8d6a-762d-e053-3705fe0a30e0 15
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer, file de3e52b0-d34d-762d-e053-3705fe0a30e0 14
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation, file de3e52b1-5775-762d-e053-3705fe0a30e0 10
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going, file de3e52b3-6268-762d-e053-3705fe0a30e0 6
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer, file de3e52b1-4ef4-762d-e053-3705fe0a30e0 4
Liquid biopsy tracking of lung tumor evolutions over time, file de3e52b3-7ca7-762d-e053-3705fe0a30e0 3
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation, file de3e52b3-5312-762d-e053-3705fe0a30e0 2
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer, file de3e52b3-5428-762d-e053-3705fe0a30e0 2
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy, file de3e52b3-0dcb-762d-e053-3705fe0a30e0 1
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance, file de3e52b3-8fb7-762d-e053-3705fe0a30e0 1
Totale 296
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 1 3 1 3 0 11 16
2020/2021103 3 9 9 7 1 5 6 1 10 30 3 19
2021/202229 1 5 2 2 5 3 4 2 2 1 2 0
2022/202376 1 1 2 0 2 2 1 2 54 0 11 0
2023/202448 6 1 7 7 2 1 10 0 8 2 4 0
Totale 296